Skip to main content

Rima Fathi Kaddurah-Daouk

Professor in Psychiatry and Behavioral Sciences
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Box 102506, Durham, NC 27710
2400 Pratt St, 7th Floor Room 7018, Durham, NC 27710

Selected Grants


Duke University Psychiatry Physician-Scientist Residency Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Prenatal maternal obesity and neurodevelopment: The mediating role of the microbiome and metabolome

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease

ResearchPrincipal Investigator · Awarded by National Institute on Aging · 2023 - 2028

Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations-Core 2-Omics Core

ResearchPrincipal Investigator · Awarded by Mayo Clinic Jacksonville · 2023 - 2028

Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations-Core 3-Analytical Core

ResearchPrincipal Investigator · Awarded by Mayo Clinic Jacksonville · 2023 - 2028

Duke University Psychiatry Physician-Scientist Residency Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Prenatal maternal obesity and neurodevelopment: The mediating role of the microbiome and metabolome

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease

ResearchPrincipal Investigator · Awarded by National Institute on Aging · 2023 - 2028

Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations-Core 2-Omics Core

ResearchPrincipal Investigator · Awarded by Mayo Clinic Jacksonville · 2023 - 2028

Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations-Core 3-Analytical Core

ResearchPrincipal Investigator · Awarded by Mayo Clinic Jacksonville · 2023 - 2028

A systems multi-omics approach to drug repositioning in Alzheimer's disease

ResearchPrincipal Investigator · Awarded by Weill Cornell Medicine · 2021 - 2025

Alzheimer's Gut Microbiome Project

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024

The UCSD Microbiome and Metagenomic Center

ResearchPrincipal Investigator · Awarded by University of California - San Diego · 2022 - 2023

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023

Gut Liver Brain Biochemical Axis in Alzheimer's Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023

Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023

IU/JAX/Pitt MODEL-AD: Identification and Validation of Metabolomic Signatures of Late-Onset Alzheimer's Disease

ResearchPrincipal Investigator · Awarded by Indiana University · 2020 - 2022

GOLDILOKs: Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids

ResearchPrincipal Investigator · Awarded by The Children's Mercy Hospital · 2016 - 2022

Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2022

IU/JAX/Pitt MODEL-AD: Verubecestat Metabolomics & Proteomics

ResearchPrincipal Investigator · Awarded by Indiana University · 2020 - 2021

Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease

ResearchPrincipal Investigator · Awarded by The Trustees of Columbia University · 2015 - 2021

Metabolomic pathways in Food Allergy

ResearchPrincipal Investigator · Awarded by Boston Children's Hospital · 2018 - 2021

AMP AD Project B Biomarker Pilot Study: An integrated biomarker discovery pilot study (Broad/Rush-Emory-Duke)

ResearchPrincipal Investigator · Awarded by Foundation for the National Institutes of Health · 2016 - 2020

Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2020

Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2020

Integrative translational discovery of vascular risk factors in aging and dementia

ResearchPrincipal Investigator · Awarded by Mayo Clinic · 2017 - 2020

Inherited Variations in Drug Metabolizing Enzymes

ResearchPrincipal Investigator · Awarded by Mayo Clinic · 2012 - 2020

A Biomarker-Based Trial of Plasmalogen Repletion in MCI/AD

ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2019 - 2020

Ex vivo metabolomic profiling of statin-induced myopathy

ResearchInvestigator · Awarded by American Heart Association · 2017 - 2019

The IU/JAX Alzheimer's Disease Precision Models Center

ResearchPrincipal Investigator · Awarded by Indiana University · 2017 - 2019

Metabolic Networks and Pathways in Alzheimer's Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2019

Metabolomic Platforms Testing for Neurosteroid Effects

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017

Metabolic Signature for Ketamine Exposure

ResearchPrincipal Investigator · Awarded by Johnson & Johnson · 2013 - 2017

Alzheimer's Disease Neuroimaging Initiative

ResearchPrincipal Investigator · Awarded by Northern California Institute for Research and Education · 2014 - 2016

INDICIES: INDIviualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1)

ResearchPrincipal Investigator · Awarded by Mental Health Centre Sct. Hans · 2015 - 2016

The Metabolomics Data Center and Workbench (MDCW)

ResearchPrincipal Investigator · Awarded by University of California - San Diego · 2012 - 2015

Metabolic Signature for Ketamine Exposure and Ketamine Response

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2014

Metabolomic Study of Reproductive Steriods

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2014

Metabolomic Signatures and Biomarkers for Schizophrenia

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2013

Metabolomics 2012

ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2013

Metabolomics Network for Drug Response Phenotype

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012

Metabolomics Network for Drug Response Phenotype

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2011

Metabolic Signatures for Alzheimer's Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2011

Pharmacometabolomics Research Network

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2011

Administrative Supplement to Metabolic Signatures for Alzheimer's Disease

Institutional SupportPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2010

Tryptophan Metabolism, Genes, and Major Depression

ResearchConsultant · Awarded by National Institutes of Health · 2006 - 2008

Metabolomic Profile of Samples from Patients with Mood and Anxiety Disorders

ResearchPrincipal Investigator · Awarded by National Institute of Mental Health · 2006 - 2007

External Relationships


  • Chymia PsyProtix
  • Metabolon

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.